Voyager Therapeutics (VYGR) Interest & Investment Income (2015 - 2026)
Voyager Therapeutics (VYGR) reported Interest & Investment Income of -$295000.0 for Q1 2026, down 241.83% on a YoY basis from $208000.0 in Q1 2025, and down 1280.0% sequentially from $25000.0 in Q4 2025.
Voyager Therapeutics (VYGR) Interest & Investment Income (2015 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 12 years of Interest & Investment Income data on file, last reported at -$295000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 241.83% year-over-year to -$295000.0; the trailing twelve-month figure through Mar 2026 stood at -$64000.0 (down 120.85% YoY), and the FY2025 full-year result was $439000.0, up 222.28% from the prior year.
- Interest & Investment Income slipped to -$295000.0 in Q1 2026, from $25000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $489000.0 in Q3 2024 to a low of -$458000.0 in Q1 2024.
- A 5-year average of -$7352.9 and a median of -$1000.0 in 2023 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 1450.0% in 2022, while the deepest fall reached 4600.0% in 2022.
- Tracing VYGR's Interest & Investment Income over 5 years: stood at $118000.0 in 2022, then surged by 69.49% to $200000.0 in 2023, then slumped by 287.0% to -$374000.0 in 2024, then surged by 106.68% to $25000.0 in 2025, then sank by 1280.0% to -$295000.0 in 2026.
- Business Quant data shows VYGR's Interest & Investment Income at -$295000.0 in Q1 2026, $25000.0 in Q4 2025, and $228000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | -295,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -295,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | 208,000.00 |
| Dec 31, 2024 | -374,000.00 |
| Sep 30, 2024 | 489,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -458,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | -115,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 87,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | -141,000.00 |
| Mar 31, 2022 | -85,000.00 |
| Dec 31, 2021 | -10,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -3,000.00 |